Computerized Physician Order Entry (CPOE) can help healthcare organizations realize substantial improvements in the quality of care and patient safety. Federal American Recovery and Reinvestment Act of 2009 (ARRA) subsidies are driving rapid uptake of CPOE implementations, all with the goal of leveraging the benefits that can come from computerized oversight and guidance of clinical pathology laboratory test results and therapy drug order management.
CPOE is an important decision-support tool for physicians at the point-of-care (POC). Regular use of a CPOE is also something that the federal government specifically identified as necessary to accomplish “meaningful use” under the ARRA/HITECH Act legislation. Medicare & Medicade subsidize an incentive program for EHR, and provide a Requirements Overview.
Unfortunately, CPOE use doesn’t always equal effectiveness. According to the Leapfrog Group’s recent report, 52% of adult hospitals in the study did not receive an appropriate warning of medication orders with potential errors. In addition, 32.8% of potentially fatal errors did not result in appropriate warnings1. Amongst pediatric hospitals, results were similarly alarming. This staggering rate of potentially fatal errors demonstrates the clear opportunity for improvement in CPOE.
TestStream’s thorough and comprehensive validation capabilities can isolate these critical alert and interface failures. Tests only take minutes to configure for even the most complicated system configurations, and are easily run regularly to provide regression assurance that your healthcare information system performance always meets with your healthcare delivery and patient safety goals.
Contact us today to learn more about how Vedant can help you get the most out of your investment in CPOE.
1Leapfrog Group Report on CPOE Evaluation Tool Results, June 2008 to January 2010